Abstract:Objective and BackgroundThe clinical trials community has been hesitant to adopt Bayesian statistical methods, which are often more flexible and efficient with more naturally interpretable results than frequentist methods. We aimed to identify self-reported barriers to implementing Bayesian methods and preferences for becoming comfortable with them.MethodsWe developed a 22-question survey submitted to medical researchers (non-statisticians) from industry, academia, and regulatory agencies. Question areas included demographics, experience, comfort levels with Bayesian analyses, perceived barriers to these analyses, and preferences for increasing familiarity with Bayesian methods.ResultsOf the 323 respondents, most were affiliated with pharmaceutical companies (33.4%), clinical research organizations (29.7%), and regulatory agencies (18.6%). The rest represented academia, medical practice, or other. Over 56% of respondents expressed little to no comfort in interpreting Bayesian analyses. “Insufficient knowledge of Bayesian approaches” was ranked the most important perceived barrier to implementing Bayesian methods by a plurality (48%). Of the approaches listed, in-person training was the most preferred for gaining comfort with Bayesian methods.ConclusionsBased on these survey results, we recommend that introductory level training on Bayesian statistics be presented in an in-person workshop that could also be broadcast online with live Q&A. Other approaches such as online training or collaborative projects may be better suited for higher-level trainings where instructors may assume a baseline understanding of Bayesian statistics. Increased coverage of Bayesian methods at medical conferences and medical school trainings would help improve comfort and overcome the substantial knowledge barriers medical researchers face when implementing these methods.

Fisher, Neyman, and Bayes at FDA.

Application of Bayesian approaches in drug development: starting a virtuous cycle

Beyond 'statistical significance': A nontechnical primer of Bayesian statistics and Bayes factors for health researchers

Bayesianly Justifiable and Relevant Frequency Calculations for the Applied Statistician

Bayesian statistical concepts with examples from rodent toxicology studies

Bayesian Approach for Design and Analysis of Medical Device Trials in the Era of Modern Clinical Studies

Bayesian Models and Methods in Public Policy and Government Settings

Bayesian Methods in Human Drug and Biological Products Development in CDER and CBER

Using Bayesian Statistics in Confirmatory Clinical Trials in the Regulatory Setting

Bayesian statistics for clinical research

Why are not There More Bayesian Clinical Trials? Perceived Barriers and Educational Preferences Among Medical Researchers Involved in Drug Development

Incentive-Theoretic Bayesian Inference for Collaborative Science

Bayesian Statistics Then and Now

Fisher Meets Bayes: The Value of Randomisation for Bayesian Inference of Causal Effects

"Not only defended but also applied": The perceived absurdity of Bayesian inference

Bayesian Statistics in Software Engineering: Practical Guide and Case Studies

Bayesian Inference for Causal Effects

Fiducial inference viewed through a possibility-theoretic inferential model lens

Joining Forces of Bayesian and Frequentist Methodology: A Study for Inference in the Presence of Non-Identifiability

The Future of Indirect Evidence

Fiducialize statistical significance: transforming p-values into conservative posterior probabilities and Bayes factors